Showing results (901-910 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|August 4, 2026
Impact of sublingual immunotherapy with dust mite drops on ECP, TARC, VCAM-1 inflammatory status in patients with allergic rhinitisBangyu Deng, Yunxia Zhao, Jisheng LiuImmunotherapy|August 7, 2026
Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiencyRoberto Crea, Elena Perez, Chaim M RoifmanImmunotherapy|August 21, 2026
The role of artificial intelligence in predicting immunotherapy treatment outcomes based on gut microbiota composition in cancer patients: a meta-analysisLeen Alhassan, Bassel Alrabadi, Suhel F Batarseh, et al.Immunotherapy|August 22, 2026
Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectivesAditya Raj, Zuber Khan, Mumtaz, et al.Immunotherapy|August 24, 2026
Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancerAlfredo Tartarone, Raffaele Conca, Alessandra Perrone, et al.Immunotherapy|November 16, 2021
Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeuticConstanza Savid-Frontera, Maria E Viano, Natalia S Baez, et al.Immunotherapy|November 15, 2021
Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summaryThomas Bieber, Eric L Simpson, Jonathan I Silverberg, et al.Immunotherapy|November 8, 2021
A summertime pause in immunoglobulin replacement therapy: a prospective real-world analysisVictor Hémar, Etienne Rivière, Carine Greib, et al.Immunotherapy|November 30, 2021
Efficacy of mite allergen immunotherapy in allergic rhinitis and the immune synergistic effect on cross-allergensPeiyan Zheng, Xiaoqing Liu, Lili Lin, et al.Immunotherapy|February 22, 2019
Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature reviewSeren Durer, Ceren Durer, Madeeha Shafqat, et al.Pageof 188